A WINDOW INTO THE WORLD OF CBD STUDIES
Although this year hasn ’ t gone according to plan for most , research on CBD & medical cannabis has continued despite Covid-19 . We ’ ve handpicked four studies from this year you need to know about .
Words by Caroline Barry
Med cann study gives hope to chemotherapy patients
Medical cannabis shows promise in reducing nausea and vomiting caused by chemotherapy , a worldfirst clinical trial has found .
In the study , published in the journal Annals of Oncology , 81 patients who had suffered from vomiting and nausea during chemotherapy were given either an oral dose of 2.5mg CBD / 2.5mg THC or a placebo , three times a day .
All of the patients had previously taken nausea prevention medication that had proven ineffective .
At the end of the Phase II component of the study , a quarter of the medical cannabis patients experienced a complete elimination of nausea and vomiting , compared to 14 percent in the placebo group .
If medical cannabis is deemed to be sufficiently effective after further study , it could be considered for routine cancer care .
Med cann is a ‘ yes-brainer ’ in older patients
Medical cannabis does not impair cognitive function in older adults , a new study from the School of Public Health at the University of Haifa has found . The study , published in the journal , Drug and Alcohol Review , included 125 patients over the age of 50 of which 63 were licensed to use medical cannabis for chronic pain .
The participants completed computerized tests evaluating their psychomotor reactions , concentration and memory and learning capacity after using cannabis for one year .
The results showed that medical cannabis does not affect cognitive function in people over 50 if used to relive chronic pain . Areas such as concentration , memory and learning abilities were no different to those not using the plant .
The researchers hope that the findings will alleviate concern about its use for chronic pain which affects 19-37 % of the elderly population .
88